Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatocyte-Targeted Drug Delivery Strategies for Chronic Hepatitis B: Overcoming Delivery Barriers Toward Functional Cure. | Pharmaceutics | 2026 | 41754954 | PubTator, text mining | PubMed |
| Hepatitis D Virus: Enigmas and Gaps of Knowledge. | Viruses | 2026 | 41754587 | PubTator, text mining | PubMed |
| Development of a Novel Human Hepatoma Cell Line Supporting the Replication of a Recombinant HBV Genome with a Reporter Gene. | Viruses | 2026 | 41754530 | PubTator, text mining | PubMed |
| IL-37 and IL-36 Cytokine Profiles in Chronic Hepatitis Delta During Bulevirtide Therapy. | Pathogens | 2026 | 41754450 | PubTator, text mining | PubMed |
| Dynamics and Sensitivity of the Lifecycle of Hepatitis B Virus. | Pathogens | 2026 | 41754425 | PubTator, text mining | PubMed |
| Challenges and Solutions in pgRNA Measurement: Toward Improved Monitoring of Hepatitis B Therapy. | Pathogens | 2026 | 41754406 | PubTator, text mining | PubMed |
| The Gut-Liver Axis in MASLD: From Host-Microbiome Crosstalk to Precision Therapeutics. | Microorganisms | 2026 | 41753757 | PubTator, text mining | PubMed |
| Indocyanine-Green-Guided Partial Nephrectomy: A Narrative Review Addressing Protocol Heterogeneity, Perioperative Functional and Oncological Outcomes. | Medicina (Kaunas) | 2026 | 41752746 | PubTator, text mining | PubMed |
| Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver. | Biomolecules | 2026 | 41750269 | PubTator, text mining | PubMed |
| Alpha-1B Glycoprotein Is a Novel Hepatocyte-Derived Host Factor Associated with In Vitro Inhibition of HBV Replication and Hepatocellular Carcinoma Progression. | Cancers (Basel) | 2026 | 41749914 | PubTator, text mining | PubMed |
| A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapy. | Med Phys | 2026 | 41746195 | PubTator, text mining | PubMed |
| Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps. | Vaccines (Basel) | 2026 | 41746099 | PubTator, text mining | PubMed |
| Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer. | Cells | 2026 | 41744798 | PubTator, text mining | PubMed |
| Constitutional indocyanine green excretion defect in a Chinese patient without underlying liver disease: case report and mechanistic insights. | Front Med (Lausanne) | 2026 | 41737405 | PubTator, text mining | PubMed |
| Application of nanoparticles in antibody drug delivery. | Front Bioeng Biotechnol | 2026 | 41725956 | PubTator, text mining | PubMed |
| Pediatric Cholestatic Diseases in the Era of Ileal Bile Acid Transporter (IBAT) Inhibitors. | Pediatr Rep | 2026 | 41718432 | PubTator, text mining | PubMed |
| Developing an automatic decision-assistance tool to choose proton/photon radiotherapy for patients with prostate cancer. | J Appl Clin Med Phys | 2026 | 41704219 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensation. | Wien Klin Wochenschr | 2026 | 41642318 | PubTator, text mining | PubMed |
| Microbiota in cancer: current understandings and future perspectives. | Signal Transduct Target Ther | 2026 | 41629271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=3